NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission last week, CareDx announced that its CareDx Pty subsidiary had agreed to purchase from Illumina affiliate Conexio Genomics certain property and assets related to HLA typing for sequencing using capillary electrophoresis-based methods.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.